Effects of benznidazole:cyclodextrin complexes on the drug bioavailability upon oral administration to rats.

[1]  Marcílio Cunha-Filho,et al.  Modulated dissolution rate from the inclusion complex of antichagasic benznidazole and cyclodextrin using hydrophilic polymer , 2013, Pharmaceutical development and technology.

[2]  P. J. Rolim-Neto,et al.  Benznidazole drug delivery by binary and multicomponent inclusion complexes using cyclodextrins and polymers. , 2012, Carbohydrate polymers.

[3]  C. Garnero,et al.  Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization. , 2012, Journal of pharmaceutical and biomedical analysis.

[4]  C. Salomon.  First century of Chagas' disease: an overview on novel approaches to nifurtimox and benzonidazole delivery systems. , 2012, Journal of pharmaceutical sciences.

[5]  Jianbin Chao,et al.  Investigation of the inclusion behavior of chlorogenic acid with hydroxypropyl-β-cyclodextrin. , 2012, International journal of biological macromolecules.

[6]  R. Figueiredo,et al.  Study of benznidazole–cyclodextrin inclusion complexes, cytotoxicity and trypanocidal activity , 2012, Journal of Inclusion Phenomena and Macrocyclic Chemistry.

[7]  J. José,et al.  IMPROVING THE SOLUBILITY OF THE ANTICHAGASIC DRUG BENZNIDAZOLE THROUGH FORMATION OF INCLUSION COMPLEXES WITH CYCLODEXTRINS , 2011 .

[8]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes , 2011, The Journal of pharmacy and pharmacology.

[9]  P. J. Rolim-Neto,et al.  The use of solid dispersion systems in hydrophilic carriers to increase benzonidazole solubility. , 2011, Journal of pharmaceutical sciences.

[10]  Marcílio Cunha-Filho,et al.  Development of effervescent tablets containing benznidazole complexed with cyclodextrin , 2011, The Journal of pharmacy and pharmacology.

[11]  L. Weiss,et al.  Chagas Disease Has Now Gone Global , 2011, PLoS neglected tropical diseases.

[12]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins: basic science and product development , 2010, The Journal of pharmacy and pharmacology.

[13]  J. D. Souza,et al.  CARACTERIZAÇÃO FÍSICO-QUÍMICA DO FÁRMACO ANTICHAGÁSICO BENZNIDAZOL , 2010 .

[14]  R. Nageswara Rao,et al.  Two-dimensional LC-MS/MS determination of antiretroviral drugs in rat serum and urine. , 2009, Journal of pharmaceutical and biomedical analysis.

[15]  R. N. Rao,et al.  Separation of stereoisomers of sertraline and its related enantiomeric impurities on a dimethylated beta-cyclodextrin stationary phase by HPLC. , 2009, Journal of pharmaceutical and biomedical analysis.

[16]  K. Ashok,et al.  Cyclodextrins as Drug Carrier Molecule: A Review , 2008 .

[17]  Rajeswari Challa,et al.  Cyclodextrins in drug delivery: An updated review , 2005, AAPS PharmSciTech.

[18]  L. Miller,et al.  The utility of cyclodextrins for enhancing oral bioavailability. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[19]  A. Al-Marzouqi,et al.  Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide. , 2007, Journal of pharmaceutical and biomedical analysis.

[20]  Thorsteinn Loftsson,et al.  Effects of cyclodextrins on drug delivery through biological membranes. , 2007, Journal of pharmaceutical sciences.

[21]  K. Hattori,et al.  Detection of environmental chemicals by SPR assay using branched cyclodextrin as sensor ligand , 2007 .

[22]  H. Heerklotz,et al.  Interactions of cholesterol with lipid membranes and cyclodextrin characterized by calorimetry. , 2005, Biophysical journal.

[23]  M. Morilla,et al.  Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough. , 2004, International journal of pharmaceutics.

[24]  E. D. Valle,et al.  Cyclodextrins and their uses: a review , 2004 .

[25]  S. Furlanetto,et al.  Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers. , 2002, Journal of pharmaceutical and biomedical analysis.

[26]  F. Hirayama,et al.  Improvement of Solubility and Oral Bioavailability of Rutin by Complexation with 2-Hydroxypropyl-β-cyclodextrin , 2000, Pharmaceutical development and technology.

[27]  K. A. Khan.  The concept of dissolution efficiency , 1975, The Journal of pharmacy and pharmacology.